
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Cancer Microbiome: Recent Highlights and Knowledge Gaps
Reece J. Knippel, Julia L. Drewes, Cynthia L. Sears
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2378-2395
Open Access | Times Cited: 75
Reece J. Knippel, Julia L. Drewes, Cynthia L. Sears
Cancer Discovery (2021) Vol. 11, Iss. 10, pp. 2378-2395
Open Access | Times Cited: 75
Showing 1-25 of 75 citing articles:
Targeting the gut and tumor microbiota in cancer
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 333
Elizabeth M. Park, Manoj Chelvanambi, Neal Bhutiani, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 690-703
Closed Access | Times Cited: 333
Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study
Yiwen Long, Lanhua Tang, Yangying Zhou, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 266
Yiwen Long, Lanhua Tang, Yangying Zhou, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 266
Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 167
Lin-Yong Zhao, Jia-Xin Mei, Gang Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 167
Context-Specific Determinants of the Immunosuppressive Tumor Microenvironment in Pancreatic Cancer
Chiara Falcomatà, Stefanie Bärthel, Günter Schneider, et al.
Cancer Discovery (2023) Vol. 13, Iss. 2, pp. 278-297
Open Access | Times Cited: 104
Chiara Falcomatà, Stefanie Bärthel, Günter Schneider, et al.
Cancer Discovery (2023) Vol. 13, Iss. 2, pp. 278-297
Open Access | Times Cited: 104
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 62
Shaosen Zhang, Xinyi Xiao, Yonglin Yi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 62
The microbial landscape of colorectal cancer
Maxwell T. White, Cynthia L. Sears
Nature Reviews Microbiology (2023) Vol. 22, Iss. 4, pp. 240-254
Closed Access | Times Cited: 59
Maxwell T. White, Cynthia L. Sears
Nature Reviews Microbiology (2023) Vol. 22, Iss. 4, pp. 240-254
Closed Access | Times Cited: 59
The oral–gut microbiome axis in health and disease
Benoît J. Kunath, Charlotte De Rudder, Cédric C. Laczny, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 12, pp. 791-805
Closed Access | Times Cited: 35
Benoît J. Kunath, Charlotte De Rudder, Cédric C. Laczny, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 12, pp. 791-805
Closed Access | Times Cited: 35
Microbiome Integrity Enhances the Efficacy and Safety of Anticancer Drug
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access | Times Cited: 3
Alice Njolke Mafe, Dietrich Büsselberg
Biomedicines (2025) Vol. 13, Iss. 2, pp. 422-422
Open Access | Times Cited: 3
A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma
Jinhuan Yang, Qikuan He, Fei Lü, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Jinhuan Yang, Qikuan He, Fei Lü, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 30
The Interaction between Intratumoral Microbiome and Immunity Is Related to the Prognosis of Ovarian Cancer
Dashuang Sheng, Kaile Yue, Hongfeng Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 26
Dashuang Sheng, Kaile Yue, Hongfeng Li, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 2
Open Access | Times Cited: 26
Gut microbial metabolites in lung cancer development and immunotherapy: Novel insights into gut-lung axis
Xinpei Li, Shijie Shang, Meng Wu, et al.
Cancer Letters (2024) Vol. 598, pp. 217096-217096
Closed Access | Times Cited: 11
Xinpei Li, Shijie Shang, Meng Wu, et al.
Cancer Letters (2024) Vol. 598, pp. 217096-217096
Closed Access | Times Cited: 11
Advances and challenges of first-line immunotherapy for non-small cell lung cancer: A review
Haiyang Guo, Jun Zhang, Chao Qin, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36861-e36861
Open Access | Times Cited: 9
Haiyang Guo, Jun Zhang, Chao Qin, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36861-e36861
Open Access | Times Cited: 9
Tumor microbiome diversity influences papillary thyroid cancer invasion
Lijuan Yuan, Ping Yang, Gang Wei, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 34
Lijuan Yuan, Ping Yang, Gang Wei, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 34
Diet-microbiome interactions in cancer treatment: Opportunities and challenges for precision nutrition in cancer
K. Leigh Greathouse, Madhur Wyatt, Abigail Johnson, et al.
Neoplasia (2022) Vol. 29, pp. 100800-100800
Open Access | Times Cited: 32
K. Leigh Greathouse, Madhur Wyatt, Abigail Johnson, et al.
Neoplasia (2022) Vol. 29, pp. 100800-100800
Open Access | Times Cited: 32
Bladder cancer-associated microbiota: Recent advances and future perspectives
Wentao Zhang, Fuhan Yang, Shiyu Mao, et al.
Heliyon (2023) Vol. 9, Iss. 1, pp. e13012-e13012
Open Access | Times Cited: 17
Wentao Zhang, Fuhan Yang, Shiyu Mao, et al.
Heliyon (2023) Vol. 9, Iss. 1, pp. e13012-e13012
Open Access | Times Cited: 17
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 8
Hao Zhang, Li Fu, Xinwen Leiliang, et al.
Cancer Communications (2024) Vol. 44, Iss. 10, pp. 1130-1167
Open Access | Times Cited: 8
Disruption of the intestinal clock drives dysbiosis and impaired barrier function in colorectal cancer
Rachel C. Fellows, Sung Kook Chun, Natalie Larson, et al.
Science Advances (2024) Vol. 10, Iss. 39
Open Access | Times Cited: 8
Rachel C. Fellows, Sung Kook Chun, Natalie Larson, et al.
Science Advances (2024) Vol. 10, Iss. 39
Open Access | Times Cited: 8
The role of short-chain fatty acids in cancer prevention and cancer treatment
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110172-110172
Open Access | Times Cited: 8
Balaraman Kalyanaraman, Gang Cheng, Micaël Hardy
Archives of Biochemistry and Biophysics (2024) Vol. 761, pp. 110172-110172
Open Access | Times Cited: 8
Tumor microenvironment‐regulating nanomedicine design to fight multi‐drug resistant tumors
Qinqin Xu, Xinyue Lan, Huimin Lin, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 1
Closed Access | Times Cited: 28
Qinqin Xu, Xinyue Lan, Huimin Lin, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 1
Closed Access | Times Cited: 28
Tumor-colonized Streptococcus mutans metabolically reprograms tumor microenvironment and promotes oral squamous cell carcinoma
Jiaying Zhou, Zixuan Hu, Lei Wang, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Jiaying Zhou, Zixuan Hu, Lei Wang, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 6
Etiopathogenesis of ovarian cancer. An inflamm-aging entity?
Manuel Sánchez‐Prieto, Rafael Sánchez-Borrego, Daniel Maria Lubián-López, et al.
Gynecologic Oncology Reports (2022) Vol. 42, pp. 101018-101018
Open Access | Times Cited: 20
Manuel Sánchez‐Prieto, Rafael Sánchez-Borrego, Daniel Maria Lubián-López, et al.
Gynecologic Oncology Reports (2022) Vol. 42, pp. 101018-101018
Open Access | Times Cited: 20
Helicobacter pylori infection altered gastric microbiota in patients with chronic gastritis
Zhaolai Hua, Le Xu, Jiahui Zhu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 13
Zhaolai Hua, Le Xu, Jiahui Zhu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 13
Awareness of intratumoral bacteria and their potential application in cancer treatment
Liang Yin, Qiyan Li, Yulin Liu, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
Liang Yin, Qiyan Li, Yulin Liu, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 12
The Gut Microbiome and Metastatic Renal Cell Carcinoma
Luís Meza, Matthew I. Feng, Kyle O. Lee, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1502-1502
Open Access | Times Cited: 11
Luís Meza, Matthew I. Feng, Kyle O. Lee, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1502-1502
Open Access | Times Cited: 11
The Role of the Gut Microbiome in Cancer: A Review, With Special Focus on Colorectal Neoplasia and Clostridioides difficile
Sean M. Anderson, Cynthia L. Sears
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_6, pp. S471-S478
Open Access | Times Cited: 11
Sean M. Anderson, Cynthia L. Sears
Clinical Infectious Diseases (2023) Vol. 77, Iss. Supplement_6, pp. S471-S478
Open Access | Times Cited: 11